PEG-RBVtherapy相关论文
Mutational diversity of NSSA and NS3 during triple therapy (telaprevir, pegylated-interferon-alpha 2
Background and aim: Telaprevir, a nonstructural (NS)3/4A protease inhibitor, is a direct-acting antiviral drug that inhi......